21st Jan 2016 09:15
LONDON (Alliance News) - Speciality pharmaceutical company Alliance Pharma PLC said Thursday it will report a 2015 pretax profit in line with its expectations, on revenue up more than 10%.
Alliance expects to report revenue of GBP48.2 million for 2015, up from GBP43.5 million a year before and including GBP800,000 in revenue from its acquisition of Sinclair IS Pharma PLC's healthcare products business in December.
The integration of this business is progressing well, Alliance said, and costs associated with the acquisition are expected to be in the range of GBP2 million for 2015, in line with its expectations. The Sinclair IS Pharma healthcare products business comprises of 27 products, which recorded sales of GBP43.3 million in the year to end-June 2015.
Alliance Pharma plans to announce its 2015 results April 7.
Shares in Alliance Pharma were down 2.7% at 47.70 pence Thursday morning.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2016 Alliance News Limited. All Rights Reserved.
Related Shares:
Sinclair PharmaAlliance Pharma